These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 18070122
21. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Pitman MB, Triratanachat S, Young RH, Oliva E. Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552 [Abstract] [Full Text] [Related]
22. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma. Karabork A, Kaygusuz G, Ekinci C. Pathol Res Pract; 2010 Aug 15; 206(8):572-7. PubMed ID: 20400233 [Abstract] [Full Text] [Related]
26. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. Wang L, Vuolo M, Suhrland MJ, Schlesinger K. Acta Cytol; 2006 Aug 15; 50(3):257-62. PubMed ID: 16780018 [Abstract] [Full Text] [Related]
28. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Xiao SY, Wang HL, Hart J, Fleming D, Beard MR. Am J Pathol; 2001 Oct 15; 159(4):1415-21. PubMed ID: 11583969 [Abstract] [Full Text] [Related]
29. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology. McKnight R, Nassar A, Cohen C, Siddiqui MT. Cancer Cytopathol; 2012 Aug 25; 120(4):223-9. PubMed ID: 22298472 [Abstract] [Full Text] [Related]
30. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades. Lin CC, Lin CJ, Hsu CW, Chen YC, Chen WT, Lin SM. J Gastroenterol Hepatol; 2008 Jul 25; 23(7 Pt 2):e146-52. PubMed ID: 17532784 [Abstract] [Full Text] [Related]
31. Fine needle aspiration biopsy of hepatocellular carcinoma. Value of immunocytochemical and ultrastructural studies. Guindi M, Yazdi HM, Gilliatt MA. Acta Cytol; 1994 Jul 25; 38(3):385-91. PubMed ID: 7514832 [Abstract] [Full Text] [Related]
32. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy. Simsir A, Chhieng D, Wei XJ, Yee H, Waisman J, Cangiarella J. Diagn Cytopathol; 2005 Jul 25; 33(1):3-7. PubMed ID: 15945081 [Abstract] [Full Text] [Related]
33. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, Ashida K, Kinugasa N, Yoshida K, Uematsu S, Tsuji T. Cancer; 1996 Jul 15; 78(2):232-36. PubMed ID: 8673997 [Abstract] [Full Text] [Related]
34. Diagnostic significance of aquaporin-1 in liver tumors. Mazal PR, Susani M, Wrba F, Haitel A. Hum Pathol; 2005 Nov 15; 36(11):1226-31. PubMed ID: 16260277 [Abstract] [Full Text] [Related]
35. CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis. Shousha S, Gadir F, Peston D, Bansi D, Thillainaygam AV, Murray-Lyon IM. Histopathology; 2004 Oct 15; 45(4):335-42. PubMed ID: 15469471 [Abstract] [Full Text] [Related]
36. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis]. Tátrai P. Magy Onkol; 2008 Dec 15; 52(4):379-83. PubMed ID: 19068466 [Abstract] [Full Text] [Related]
37. Hepatocyte paraffin-1, CD10, and CD34 immunostaining as a diagnostic aid in cytologic diagnosis of hepatic cancer. Agarwal A, Handa U, Kundu R, Sachdev A, Kochhar S. J Cancer Res Ther; 2022 Dec 15; 18(Supplement):S434-S438. PubMed ID: 36510999 [Abstract] [Full Text] [Related]
38. Albumin gene expression in liver tumors: diagnostic interest in fine needle aspiration biopsies. Papotti M, Pacchioni D, Negro F, Bonino F, Bussolati G. Mod Pathol; 1994 Apr 15; 7(3):271-5. PubMed ID: 8058698 [Abstract] [Full Text] [Related]
39. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Chu PG, Ishizawa S, Wu E, Weiss LM. Am J Surg Pathol; 2002 Aug 15; 26(8):978-88. PubMed ID: 12170084 [Abstract] [Full Text] [Related]
40. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy. Anatelli F, Chuang ST, Yang XJ, Wang HL. Am J Clin Pathol; 2008 Aug 15; 130(2):219-23. PubMed ID: 18628090 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]